Found: 8
Select item for more details and to access through your institution.
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
- Published in:
- Journal of NeuroVirology, 2016, v. 22, n. 1, p. 88, doi. 10.1007/s13365-015-0371-x
- By:
- Publication type:
- Article
EP23.04: The renal position index: an anatomic landmark to define the normal position of fetal kidneys at first trimester.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2022, v. 60, p. 186, doi. 10.1002/uog.25556
- By:
- Publication type:
- Article
OP05.03: Fetal ventricles evaluation at first trimester: ultrasound diagnosis and association with neural tube defects.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2022, v. 60, p. 61, doi. 10.1002/uog.25147
- By:
- Publication type:
- Article
Diagnostic accuracy of new and old cognitive screening tools for HIV‐associated neurocognitive disorders.
- Published in:
- HIV Medicine, 2018, v. 19, n. 7, p. 455, doi. 10.1111/hiv.12622
- By:
- Publication type:
- Article
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 8, p. 1938, doi. 10.1093/jac/dkt095
- By:
- Publication type:
- Article